Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion-Reference-Cited by-同舟云学术

Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion

Published:2020-09-14 Issue:5 Volume:191 Page:844-851
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Moorman Anthony V.¹^ORCID,Schwab Claire¹,Winterman Emily¹,Hancock Jerry²,Castleton Anna³,Cummins Michelle⁴,Gibson Brenda⁵,Goulden Nick⁶,Kearns Pam⁷^ORCID,James Beki⁸,Kirkwood Amy A.⁹,Lancaster Donna¹⁰,Madi Mabrouk¹¹,McMillan Andrew¹²,Motwani Jayashree¹³,Norton Alice¹³,O’Marcaigh Aengus¹⁴,Patrick Katharine¹⁵,Bhatnagar Neha¹⁶,Qureshi Amrana¹⁶^ORCID,Richardson Deborah¹⁷,Stokley Simone¹⁸,Taylor Gordon¹⁹,Delft Frederik W.¹,Moppett John⁴,Harrison Christine J.¹,Samarasinghe Sujith⁶^ORCID,Vora Ajay⁶

Affiliation:

1. Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

2. Bristol Genetics Laboratory North Bristol NHS Trust Bristol UK

3. Department of Haematology The Christie Hospital NHS Trust Manchester UK

4. Department of Paediatric Oncology Bristol Royal Hospital for Children Bristol UK

5. Department of Haematology Royal Hospital for Children Glasgow UK

6. Department of Haematology Great Ormond Street Hospital London UK

7. Institute of Cancer and Genomic Sciences and NIHR Birmingham Biomedical Research Centre University of Birmingham Birmingham UK

8. Regional Centre for Paediatric Haematology and Oncology Leeds Children’s Hospital Leeds UK

9. CR UK and UCL Cancer Trials Centre UCL Cancer InstituteUCL London UK

10. Paediatric Oncology The Royal Marsden Hospital Sutton UK

11. Department of Paediatric Oncology and Haematology Leicester Royal Infirmary Leicester UK

12. Centre for Clinical Haematology Nottingham University Hospitals Nottingham UK

13. Department of Haematology Birmingham Women's and Children's NHS Foundation Trust Birmingham UK

14. Department of Haematology Children’s Health Ireland Dublin Ireland

15. Department of Haematology Sheffield Children’s NHS Foundation Trust Sheffield UK

16. Paediatric Haematology Department Oxford Children’s Hospital Oxford UK

17. Department of Haematology Southampton University Hospitals Trust Southampton UK

18. Department of Paediatric Haematology Nottingham Children’s Hospital Nottingham UK

19. Department of Haematology Aberdeen Royal Infirmary Aberdeen UK

Funder

Bloodwise

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17093

Reference16 articles.

1. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

2. Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

3. EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

4. Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease

5. BCR-ABL1 -like acute lymphoblastic leukaemia: From bench to bedside

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB‐positive acute lymphoblastic leukemia patients: A retrospective multicenter study;Cancer;2024-08-13

2. SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. Memory-like natural killer cell and CD19-antibody based immunotherapy in combination with tyrosine-kinase inhibition of Ph(-like) acute lymphoblastic leukemia;2024-06-13

4. ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia;Annals of Oncology;2024-01

5. Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL;Journal of Clinical Oncology;2023-12-20